These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11150412)

  • 21. Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients.
    Hilton S; Schrumpf H; Buhren BA; Bölke E; Gerber PA
    Eur J Med Res; 2014 May; 19(1):30. PubMed ID: 24886711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of improved myocardial protection on edema and diastolic properties of the rat left ventricle during acute allograft rejection.
    Soto PF; Jia CX; Carter YM; Rabkin D; Starr JP; Amirhamzeh MM; Hsu DT; Sciacca R; Fisher PE; Spotnitz HM
    J Heart Lung Transplant; 1998 Jun; 17(6):608-16. PubMed ID: 9662097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy.
    Salkie ML
    Clin Biochem; 1980 Apr; 13(2):92-4. PubMed ID: 7389076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury.
    George J; Stern R
    Clin Chim Acta; 2004 Oct; 348(1-2):189-97. PubMed ID: 15369754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of hyaluronan hydrolysis catalysed by hyaluronidase at high substrate concentration and low ionic strength.
    Astériou T; Vincent JC; Tranchepain F; Deschrevel B
    Matrix Biol; 2006 Apr; 25(3):166-74. PubMed ID: 16380245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of hyaluronidase for pharmacokinetic increase in bioavailability of intracutaneously applied substances.
    Wohlrab J; Wohlrab D; Wohlrab L; Wohlrab C; Wohlrab A
    Skin Pharmacol Physiol; 2014; 27(5):276-82. PubMed ID: 24944044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronidase modulates bleomycin-induced lung injury detected noninvasively in small rodents by radial proton MRI.
    Egger C; Cannet C; Gérard C; Dunbar A; Tigani B; Beckmann N
    J Magn Reson Imaging; 2015 Mar; 41(3):755-64. PubMed ID: 24623374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of fibroblasts by activated and non-activated immune cells.
    Johnsson C; Lorant T; Tufveson G
    J Heart Lung Transplant; 2005 Dec; 24(12):2170-8. PubMed ID: 16364867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondroprotective action of chondroitin sulfate. Competitive action of chondroitin sulfate on the digestion of hyaluronan by bovine testicular hyaluronidase.
    Bartolucci C; Cellai L; Corradini C; Corradini D; Lamba D; Veloná I
    Int J Tissue React; 1991; 13(6):311-7. PubMed ID: 1818045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of commonly used immunosuppressants on graft-derived fibroblasts.
    Johnsson C; Gerdin B; Tufveson G
    Clin Exp Immunol; 2004 Jun; 136(3):405-12. PubMed ID: 15147341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection.
    Delpech B; Bertrand P; Maingonnat C; Girard N; Chauzy C
    Anal Biochem; 1995 Jul; 229(1):35-41. PubMed ID: 8533892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
    Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
    J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental study of cardiac lymph dynamics and edema formation in ischemia/reperfusion injury--with reference to the effect of hyaluronidase.
    Yotsumoto G; Moriyama Y; Yamaoka A; Taira A
    Angiology; 1998 Apr; 49(4):299-305. PubMed ID: 9555933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of hyaluronidase and protamine on resistance and transport after coronary flow reduction in heparinized dogs.
    Overholser KA; Harris TR
    J Pharmacol Exp Ther; 1981 Apr; 217(1):62-9. PubMed ID: 7205660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase "Dessau"].
    Farr C; Menzel J; Seeberger J; Schweigle B
    Wien Med Wochenschr; 1997; 147(15):347-55. PubMed ID: 9432805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye.
    Knepper PA; Farbman AI; Telser AG
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):286-93. PubMed ID: 6698747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of hyaluronidase in the treatment of intravenous extravasation injuries.
    Raszka WV; Kueser TK; Smith FR; Bass JW
    J Perinatol; 1990 Jun; 10(2):146-9. PubMed ID: 2358898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous bovine testicular hyaluronidase depolymerizes myocardial hyaluronic acid in dogs with coronary artery occlusion.
    Wolf RA; Chaung LY; Muller JE; Kloner RA; Braunwald E
    Circ Res; 1981 Jan; 48(1):88-95. PubMed ID: 7438348
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes of tissue fluid hyaluronan (hyaluronic acid) in peripheral lymphedema.
    Liu NF; Zhang LR
    Lymphology; 1998 Dec; 31(4):173-9. PubMed ID: 9949388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel.
    Bishop PN; McLeod D; Reardon A
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2173-8. PubMed ID: 10476780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.